This biotech name is evolving into a major obesity play. How to trade it with options

This biotech name is evolving into a major obesity play. How to trade it with options

Amgen is entering a pivotal period the as it moves beyond its Enbrel franchise and repositions around obesity, rare disease and next-generation oncology. While Enbrel has entered a period of decline due to Medicare pricing reform, management has demonstrated credible execution in replacing that cash flow with a higher-quality pipeline. Early success from the Imdelltra…

Read More
The No.1 reason startups fail in the first two years, according to a VC

The No.1 reason startups fail in the first two years, according to a VC

Concept Ventures was an early investor in billion dollar AI firm Eleven Labs. Reece Chowdhury A venture capitalist says one of the biggest reasons startups fail hinges on the relationship between co-founders. Reece Chowdhry, founding partner of Concept Ventures, said early teams often split within two years because their co-founders clash or lack a shared…

Read More